Across TCGA pan-cancer cohorts, RPLP0P6 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of RPLP0P6’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPLP0P6 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPLP0P6 is over-expressed in tumor.
KIRC, COAD, and LIHC are the cancer types where RPLP0P6 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPLP0P6 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.